Standout Papers

Effects of Losartan on Renal and Cardiovascular Out... 1981 2026 1996 2011 5.3k
  1. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy (2001)
    Barry M. Brenner, Mark E. Cooper et al. New England Journal of Medicine
  2. Dietary Protein Intake and the Progressive Nature of Kidney Disease: (1982)
    Franklin H. Epstein, Barry M. Brenner et al. New England Journal of Medicine
  3. Hypertension : pathophysiology, diagnosis, and management (1995)
    John H. Laragh, Barry M. Brenner Raven Press eBooks
  4. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation (1981)
    Thomas H. Hostetter, Jean L. Olson et al. American Journal of Physiology-Renal Physiology
  5. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. (1986)
    Roberto Zatz, B R Dunn et al. Journal of Clinical Investigation
  6. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. (1986)
    Sharon Anderson, Helmut G. Rennke et al. Journal of Clinical Investigation
  7. Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes (2012)
    Hans‐Henrik Parving, Barry M. Brenner et al. New England Journal of Medicine
  8. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. (1985)
    Sharon Anderson, Timothy W. Meyer et al. Journal of Clinical Investigation
  9. Diverse biological actions of atrial natriuretic peptide (1990)
    Barry M. Brenner, Barbara J. Ballermann et al. Physiological Reviews
  10. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL (2004)
    Dick de Zeeuw, Giuseppe Remuzzi et al. Kidney International
  11. Glomerular hemodynamics in experimental diabetes mellitus (1981)
    Thomas H. Hostetter, Julia L. Troy et al. Kidney International
  12. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies (1982)
    Thomas H. Hostetter, Helmut G. Rennke et al. The American Journal of Medicine
  13. Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy (2004)
    Dick de Zeeuw, Giuseppe Remuzzi et al. Circulation
  14. Nephron adaptation to renal injury or ablation (1985)
    Barry M. Brenner American Journal of Physiology-Renal Physiology
  15. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease (2013)
    Valérie A. Luyckx, John F. Bertram et al. The Lancet
  16. The Dynamics of Glomerular Ultrafiltration in the Rat (1971)
    Barry M. Brenner, Julia L. Troy et al. Journal of Clinical Investigation

Immediate Impact

6 by Nobel laureates 7 from Science/Nature 125 standout
Sub-graph 1 of 15

Citing Papers

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
2013 Standout
86 intermediate papers

Works of Barry M. Brenner being referenced

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
2012 Standout
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
2001 Standout
and 53 more

Author Peers

Author Last Decade Papers Cites
Barry M. Brenner 14779 12872 7653 8398 290 38.8k
Eberhard Ritz 19039 13530 6422 9208 926 43.6k
Robert W. Schrier 10258 7479 9913 4001 563 37.6k
Mark E. Cooper 12906 12490 11408 17386 506 47.5k
William E. Mitch 11097 7778 10991 5887 298 36.5k
Friedrich C. Luft 5590 16685 12694 8911 1.0k 49.6k
Ron T. Gansevoort 11211 6883 4459 4623 459 25.9k
Peter Rossing 10797 10480 8283 22306 737 39.4k
John H. Laragh 3362 21170 5433 9352 472 35.0k
Yaping Zhang 11107 6733 2867 3407 192 27.5k
Caroline S. Fox 4251 11799 5931 9544 314 35.9k

All Works

Loading papers...

Rankless by CCL
2026